Helping make medicine personal—microarray solutions for pre-emptive pharmacogenomics

Pharmacogenomics, the understanding of how genes impact an individual’s response to medications, play an important role in certain prescribing situations by identifying medication responders and non-responders to avoid specific adverse events and optimize drug dose. 


Thermo Fisher Scientific’s microarray technology helps garner new, greater insights to help make medicine personal. Our efficient workflows provide consistent, reliable results you can replicate. We provide input on what’s needed to customize your array, with hands-on support from start to finish so you can remain focused on shaping the future of healthcare.


Customer and solutions overview

Understanding a shifting tech landscape

In this webinar we introduce three key whole-genome technologies and discuss how they can be integrated into technology strategies for your research.

Genotyping techniques used by researchers

In this webinar series, learn how genotyping techniques, including microarray analysis, next‑generation sequencing, and quantitative and digital PCR, are being used by researchers in different applications

Current state of pharmacogenomics and its future

Raymond Lorenz, the director and medical science liaison at Quest Diagnostics, shares how pharmacogenomics can assist providers in optimizing drug selection and dosing, help avoid costly adverse effects, and identify responders and nonresponders to medications.

Investigate the relationship between genotype and drug response

What’s the role of genotypes in drug metabolism? How does an individual’s genotype affect drug response? Will pharmacogenomic testing reduce healthcare costs? Find out.

Pharmacogenomics in precision medicine: Pathways to ease adoption

In this webinar Dr. Solomon Adams walks viewers through the PGx program at Ariel Precision Medicine and plans for empowering patients to use PGx data with multiple providers.

Which technology platform is right for you?

Explore the advances and trade-offs of three different technologies in the context of genomic discovery.

Custom arrays




Microarray Research Services Laboratory